Acorda Therapeutics Inc Ingresos Y/Y

¿Qué es el Ingresos Y/Y de Acorda Therapeutics Inc?

El Ingresos Y/Y de Acorda Therapeutics Inc es -0.79%

¿Cuál es la definición de Ingresos Y/Y?

El crecimiento anual de los ingresos de los últimos 3 años es el crecimiento de los ingresos de un año a otro promediado en los últimos 3 años.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Ingresos Y/Y de compañías en Sector Health Care en NASDAQ en comparadas con Acorda Therapeutics Inc

¿Qué hace Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Empresas con ingresos y/y similar a Acorda Therapeutics Inc